DSIJ Mindshare

Wockhardt receives approval for cancer drug Decibatine inj

Advait Dharmadhikari 0 1055 Article rating: 5.0

Pharma major Wockhardt has received approval from the United States Food & Drug Administration (USFDA) for an ANDA for 50 mg injection of Decibatine, which is used in the treatment of some forms of cancer. Decibatine injection is a generic version of Dacogen, marketed in the USA and other countries by Otsuka.

Index trend and stocks in action April 11, 2019

DSIJ Intelligence-3 0 1733 Article rating: 5.0

Traders will closely monitor two key levels, namely, 11,540 and 11,710, as we have seen the index has been trading in this range since last four-five trading session. Any breakout on either side of this range would lead to an explosive move. Stocks in news: JSW Steel, Wockhardt, Info Edge, Kansai Nerolac Paints, Sobha, Tanla Solutions, Wipro, TCS.

Markets may start on a tepid note tracking muted cues from Asian peers

DSIJ Intelligence-3 0 1086 Article rating: 5.0

Markets may begin the day with modest gains as indicated by the SGX Nifty and also, slightly encouraging cues from the Wall Street overnight. At the time of writing, SGX Nifty was trading higher by 22 points at 11,673 level. The much awaited event, the general election will garner the attention of the investors going ahead as the first phase of election in the world’s largest democracy begins today.

RSS
First65876588658965906592659465956596Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR